Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Design Dossier

Introduction

The Design Dossier is a comprehensive compilation of documentation that provides evidence of a medical device’s compliance with regulatory requirements. It plays a critical role in the life sciences, pharmaceutical, and biotech sectors, ensuring consistent product quality and safety throughout the product lifecycle.

Definitions and Concepts

Design Dossier: A collection of technical and clinical information supporting the conformity of a medical device to regulatory standards, typically required for higher-risk classifications of medical devices (e.g., EU Class III devices).
Technical File: While often used interchangeably with a Design Dossier, this is generally associated with devices of lower risk classifications (e.g., Class I or II under EU MDR).

The dossier typically includes elements such as device description, intended use, design verification and validation, risk management documentation, clinical evaluation, and labeling requirements.

Importance

The Design Dossier is essential for manufacturers seeking regulatory approval or market access for medical devices in regions adhering to the EU Medical Device Regulation (MDR) and other global standards like ISO 13485. Here’s why it matters:

  • Regulatory Compliance: Ensures the product meets safety and performance standards before entering the market.
  • Risk Mitigation: Documents and addresses potential risks to patients and users during the product lifecycle.
  • Transparency: Provides regulators with a clear and structured overview of the device development process.
  • Continuous Improvement: Acts as a living document that supports post-market surveillance and product updates.

Principles or Methods

The preparation of a Design Dossier follows stringent principles and methodologies:

  • Risk Management: Adheres to ISO 14971 for the identification, assessment, and control of risks throughout the device lifecycle.
  • Design Controls: Structures development activities to ensure that all specifications and performance requirements are met (21 CFR 820.30 in the US).
  • Clinical Evidence: Compiles clinical data to back claims of safety and efficacy, often derived from clinical trials or literature review.
  • Traceability: Ensures a transparent link between user needs, design inputs, design outputs, and verification/validation activities.

Application

The Design Dossier is applied extensively across various stages of the medical device lifecycle:

  • Regulatory Submissions: Companies submit the dossier to notified bodies or regulatory agencies to obtain product approval or CE marking.
  • Quality Management: Supports quality audits under ISO 13485 and other regulatory frameworks.
  • Supplier Coordination: Establishes traceability requirements and component compliance provided by suppliers.
  • Product Updates and Re-Certification: Serves as a reference during device modifications or re-assessments under new regulations.
  • Post-Market Surveillance: Offers a foundation for assessing performance after the device is commercialized.